1. Institute for Cardiovascular Prevention (IPEK), LMU Munich Hospital, Germany (A.S., A.O.-G., C.W., P. Lemnitzer, J.R.V., C.P., L.P.O., J.W., Y.D., O.S.).
2. German Center for Cardiovascular Research (DZHK), partner site Munich Heart Alliance (MHA), Munich, Germany (A.S., A.O.-G., S.L.M., L.M., O.S.).
3. Department of Biochemistry, CARIM, University Maastricht, The Netherlands (K.W., T.H., G.A.F.N.).
4. Division of Pulmonary and Critical Care Medicine (M.P.-V., R.M.B.), Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.
5. Division of Cardiovascular Medicine (E.F., P. L.), Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.
6. EpiQMAx GmbH, Planegg-Martinsried, Germany (V.S.-M., M.V.-A.).
7. Department of Microbiology, Tumor and Cell Biology (M.C.I.K.), Karolinska Institute, Stockholm, Sweden.
8. Department of General and Interventional Cardiology, University Heart Center Hamburg, Germany (T.Z.).
9. German Center for Cardiovascular Research (DZHK), Partner Site Hamburg, Lübeck, Kiel Hamburg, Germany (T.Z.).
10. BMC, Chromatin Proteomics Group, Department of Molecular Biology (A.I.), LMU München, Germany.
11. Department of Vascular and Endovascular Surgery, Technical University Munich, Germany (L.M.).
12. BMC, Metabolic Biochemistry (F.K.), LMU München, Germany.
13. Center for Nano Science (CeNS), Department of Physics, Munich, Germany (M.B.).
14. Division of Angiology, Swiss Cardiovascular Centre, Inselspital, Bern University Hospital, University of Bern, Switzerland (Y.D.).
15. Department of Physiology and Pharmacology (FyFa) (O.S.), Karolinska Institute, Stockholm, Sweden.